Stocks and Investing Stocks and Investing
Tue, September 22, 2020
Mon, September 21, 2020

Matthew O"Brien Maintained (ZBH) at Buy and Held Target at $160 on, Sep 21st, 2020


Published on 2024-10-27 13:32:24 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy and Held Target at $160 on, Sep 21st, 2020.

Matthew has made no other calls on ZBH in the last 4 months.

There are 6 other peers that have a rating on ZBH. Out of the 6 peers that are also analyzing ZBH, 0 agree with Matthew"s Rating of Hold.

These are the ratings of the 6 analyists that currently disagree with Matthew;

Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $155 on, Wednesday, August 5th, 2020
Lawrence Keusch of "Raymond James" Maintained at Strong Buy with Increased Target to $150 on, Wednesday, August 5th, 2020
Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $162 on, Wednesday, August 5th, 2020
Richard Newitter of "SVB Leerink" Maintained at Buy with Increased Target to $153 on, Wednesday, August 5th, 2020
David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Wednesday, August 5th, 2020
Jeff Johnson of "Baird" Maintained at Buy with Increased Target to $147 on, Wednesday, June 10th, 2020

Contributing Sources